Behavioral intervention, not lovastatin, improves language skills in youth with fragile X

A UC Davis Health study found more evidence for the efficacy of behavioral intervention in treating language problems in youth with fragile X syndrome (FXS), but none for lovastatin as a treatment for FXS.

Read more